|
| |
| LumiQuick and Boson's
Rapid Cardiac Marker Tests are immunochromatographic assays to quickly detect cardiac
troponin I (cTnl),CK-MB and Myoglobin in human blood specimens as an
aid in the diagnosis of
myocardial infarction. The product line includes
individual test card and multiple marker test
panel. The products are simple
to perform, quickly to get results, easy to
interpret. |
| Product
specification |
| |
|
|
|
|
|
| Tests |
Specimen |
Format |
Read Time |
Sensitivity |
Packaging |
|
Troponin I
|
Serum, plasma or whole blood |
1
Test Card |
15 minutes
|
1.5 ngfml(Abbott AxSYMj |
25 Testslkit
|
|
CK-MB
|
Serum, plasma or whole blood |
1
Test Card |
10 minutes
|
7ngfml
|
25 Testslkit
|
|
Myoglobin
|
Serum, plasma or whole blood |
1
Test Card |
10 minutes
|
100 ngfml
|
25 Testslkit
|
|
Cardiac Panel
|
Serum, plasma or whole blood |
1
Test Card |
15 minutes
|
Tn 11.5 ngfml
|
25 Testslkit
|
| Test
procedure |
|
1.
Remove the test device from the pouch.
2. Add
certain amount of sample to the device.
(
procedures varies depending on test formats)
3. Read
the results at 15 minutes.
|
Interpretation of results
|
 |
| Product
Name |
Cat.
No. |
Specimen |
Fomat |
Packaging |
CE MARKED |
|
Troponin
I Test
|
75001 |
Serum/Plasma
|
Cassette
|
25 Tests/box
|
NO |
|
Troponin
I Test
|
75002
|
Whole Blood/Serum/Plasma
|
Cassette
|
25 Tests/box
|
NO |
|
CK-MB
Test
|
7500
|
Serum/Plasma
|
Cassette
|
25 Tests/box
|
NO |
|
CK-MB
Test
|
7500
|
Whole Blood/Serum/Plasma
|
Cassette
|
25 Tests/box
|
NO |
|
Myoglobin
Test
|
75005
|
Serum/Plasma
|
Cassette
|
25 Tests/box
|
NO |
|
Myoglobin
Test
|
75006
|
Whole Blood/Serum/Plasma
|
Cassette
|
25 Tests/box
|
NO |
|
Cardiac
panel, CK-MB/Myo/TnI
|
75004
|
Serum/Plasma
|
Cassette
|
25 Tests/box
|
YES |
|
Cardiac
panel, CK-MB/Myo/TnI
|
75003
|
Whole Blood/Serum/Plasma
|
Cassette
|
25 Tests/box
|
YES |
 |
The BioNexia®
Troponin I Test is a rapid one-step chromatographic
immunoassay for the qualitative detection of human cardiac Troponin I
in whole blood, serum or plasma as an aid in the diagnosis of
myocardial infarction (MI).
Cardiac Troponin I (cTnl) is a protein found in cardiac muscle with a
molecular weight of 22.5 kDa. Troponin I is part of a three subunit
complex comprising of Troponin T and Troponin C. Along with
tropomyosin, this structural complex forms the main
component that regulates the calcium sensitive ATPase activity of
actomyosin in striated skeletal and cardiac muscle. After cardiac
injury occurs, cTnI is released into the blood 4-6 hours after the
onset of pain.
The release pattern of cTnl is similar to CK-MB, but while CK-MB levels
return to normal after 72 hours, cTnI levels remain elevated for 6-10
days, thus providing a longer window of detection for cardiac injury.
The high specificity of cTnl measurements for the identification of
myocardial damage has been demonstrated in conditions such as the
perioperative period, after marathon runs, and blunt chest trauma. cTnl
release has also been documented in cardiac conditions other than acute
myocardial infarction /AMI) such as unstable angina, congestive heart
failure, and ischemic damage due to coronary artery bypass surgery.
Because of its high specificity and sensitivity in the myocardial
tissue, cTnI has recently become the most preferred biomarker for
myocardial infarction.
The BioNexia® Troponin I Test is a simple test
that utilizes a combination of particle conjugated anti-cTnl antibodies
and capture reagent to selectively detect cTnl in whole blood, serum or
plasma. The minimum detection level is 1.0 ng/mL.
|
| ART. CODE |
NAME |
SIZE |
CE
MARKED |
| BM-TNI-4D |
BioNexia
Troponin I Test |
5 tests |
YES |
| |
|
|
|
The Bionexia®
D-dimer cassette test is a rapid, visual test for the
qualitative detection of D-dimer in plasma or whole blood.
This test is intended as an aid in the diagnosis of
disseminated intravascular coagulation (DIC), deep venous thrombosis
(DVT) and pulmonary embolism. For professional in vitro diagnostic use
only.
D-dimer testing was originally developed in the diagnosis of
disseminated intravascular coagulation (DIC). In the 1990s, it turned
out to be useful in diagnosis of thromboembolic process. D-dimer is a
fi brin degradation product, a small protein fragment present in the
blood after a blood clot is degraded by fi brinolysis. During
coagulation of blood, fi brinogen is metabolized to fi brin by thrombin
activation. Fibrin consists of D- and E- units. The cleavage of fi brin
leads to so called D-dimers. D-dimer concentration may be determined by
a blood test to help diagnose thrombosis. Since its introduction in the
1990s, it has become an important test performed patients suspected of
thrombotic disorders. While a negative result practically rules out
thrombosis, a positive result can indicate thrombosis but does not rule
out other potential etiologies. Its main use, therefore, is to exclude
thromboembolic disease where the probability is low. D-dimer testing is
of clinical use when there is a suspicion of deep venous thrombosis
(DVT) or pulmonary embolism (PE). In patients suspected of disseminated
intravascular coagulation (DIC), D-dimer testing may aid in the
diagnosis.
|
| ART. CODE |
NAME |
SIZE |
CE
MARKED |
| BM-DDI-1D |
BioNexia
D-Dimer Test |
5
tests |
YES |
| |
|
|
|
Do you have any other question? Contact us and we will help you.
|
The .pdf version of this page
is available in our
our products page.
|
| |
|
